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ABSTRACT
Objective: To compare the benefits and harms of
a Dutch 10-session Community Occupational Therapy
programme for patients with Alzheimer’s disease with
the impact of a one session consultation at home in
German routine healthcare.
Design: A seven-centre, parallel group, active
controlled randomised controlled trial. Patients and
carers were not masked. Assessors were fully blind for
treatment allocation for one of two primary-outcome
measurements.
Setting: Patients’ homes.
Participants: Patients with mild to moderate
Alzheimer’s disease (Mini-Mental State Examination
14e24), living in the community with primary carer
available and without severe depression or behavioural
symptoms, were eligible.
Interventions: Experimental 10 home visits within
5 weeks by an occupational therapist, educating
patients in the performance of simplified daily activities
and in the use of aids to compensate for cognitive
decline; and educating carers in coping with behaviour
of the patient and in giving supervision to the patient.
Control one home visit including individual counselling
of patient and carer and explanation of a leaflet on
coping with dementia in daily life.
Outcome measures: The primary outcome was the
patient’s daily functioning measured with the Interview
of Deterioration in Daily activities in Dementia and the
Perceive, Recall, Plan and Perform System of Task
Analysis. Assessments were at baseline, 6, 16 and
26 weeks, with a postal assessment at 52 weeks.
Results: 141 patients were 1:1 randomised to the
experimental (N¼71) and control group (N¼70). Data
for 54 and 50 participants were analysed. Patients’
daily functioning did not differ significantly between
the experimental and control group at week 6, 16, 26
or 52 and remained stable over 26 weeks in both
groups. No adverse events were associated with the
interventions.
Conclusions: In German healthcare, a Dutch 10-
session community occupational therapy was not
better than a one-session consultation for the daily
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functioning of patients with Alzheimer’s disease. Further research on
the transfer of complex psychosocial is needed.
International Clinical Trials Registry Platform:
DRKS00000053; Funded by the German Federal Ministry of Health.
INTRODUCTION
Alzheimer’s disease causes high healthcare costs and
burdens patients and carers with severe problems in
Activities of Daily Living (ADL).1 2 Consequently, the
improvement or the preservation of ADL is evaluated as
a patient-related outcome in clinical trials related to
dementia.3 ADL, burden of care, ability to stay in the
community and quality-of-life issues are probably much
more relevant to patients and carers than the decelera-
tion of cognitive decline, another patient-related
outcome.4 A synopsis of four systematic reviews analysing
73 RCTs on the efficacy of pharmacological and
psychosocial interventions regarding everyday func-
tioning in dementia concluded that positive effects of
drugs on ADL are small (pooled effect sizes <0.28) and
heterogeneous regarding safety. In contrast to the well-
documented results for pharmacological interventions,
evidence for psychosocial interventions on ADL is
lacking.5 However, a recent Dutch mono-centre RCT
demonstrated significant positive effects of occupational
therapy on ADL (effect sizes of 2.4, p<0.0001).6 There-
fore, the purpose of our multicentre RCT was to transfer
the Dutch community occupational therapy programme
in a broader context of German routine healthcare and
to evaluate its effectiveness and safety in comparison with
an active-control-group intervention.
Occupational therapy specialises in supporting inde-
pendence in ADL and is recommended in several
guidelines for dementia management.7e9 Occupational
therapy uses a combined approach including activity
simplification, environmental modification, adaptive
aids, problem-solving strategies, skill training and carer
training.7 10 11 According to the bio-psycho-social health
model of the WHO, the negative impact of cognitive
deficits on activities can be diminished by improving the
patient’s physical and social environment and by
tailoring the intervention to the patient’s capability.12e15
Until July 2011, there was no systematic review on
community occupational therapy for people with
Alzheimer’s disease, but two research groups had
conducted RCTs in this subject. In the USA study,
occupational therapy demonstrated beneficial effects on
patients’ challenging behaviours but not on ADL. No
information on adverse events was given.14 16e18 In the
Netherlands, occupational therapy, tailored to the needs
of patients and carers, showed benefits in the patient’s
ADL, mood, health status and quality of life and in the
carer’s sense of competence, mood, quality of life and
costs of informal care. No adverse events were reported
in either intervention or control group.6 19 20
In the current randomised trial, we tested the
hypothesis that the Dutch 10-session Community Occu-
pational Therapy in Dementia Programme (COTiD)
would significantly improve the daily functioning of
people with mild or moderate dementia, more so than
a one-session Community Occupational Therapy
Consultation (COTC). Secondary research questions
were whether these interventions would show any
difference in their effect on patient’s and primary carer’s
quality of life and mood; on the carer’s sense of
competence in the interaction with the patient; and on
long-term nursing-home placements.
METHODS
Design
In order to evaluate the superiority of COTiD, we used
a seven-centre single-blind, active-controlled design
with a 1:1 randomisation for two parallel groups. There
was no modification in design or eligibility criteria from
the study protocol available at http://www.ncbi.nlm.
nih.gov/pmc/articles/PMC2761388/. The study was
registered at the German register of clinical trials,
which is connected to the International Clinical Trials
Registry Platform (http://apps.who.int/trialsearch/
¼>DRKS00000053).
Participants and setting
Patients were eligible to participate in the study if they
had mild to moderate dementia (Mini-Mental State
Examination (MMSE) 14e24) and were diagnosed as
having Alzheimer’s disease or mixed-type dementia,
according to Tenth Revision of the International Classi-
fication of Diseases criteria, by physicians with more than
5 years of experience in dementia diagnosis. Participants
had to live in the community either together with their
primary carer or with involvement of a carer providing
care at least twice a week. Patients with a score above 12
on the 30-items Geriatric Depression Scale or a major
need of physical nursing care of more than 120 min per
day (level 2 or higher according to the German Long-
Term Care Insurance Act) were excluded. Unstable
medical conditions or severe behavioural disturbances,
which did not allow participation in the study as judged
by the study physicians, were criteria for exclusion as well
as for discontinuation. Long-term nursing-home place-
ments of the patients during the treatment phase or
death of patient or primary carer were criteria for
discontinuation. The patient gave written informed
consent, and the carer consented by written format to
join and support the treatment procedures.
Patients were recruited from five outpatient memory
centres at university hospitals (in Bonn, Freiburg, Mainz,
Marburg and Tu¨bingen); one municipal hospital in
Karlsruhe specialising in geriatric medicine; and one
neurological private practice in Berlin specialising in
neuropsychiatry and collaborating with an occupational
therapy private practice. The seven participating centres
are located throughout Germany in urban regions with
catchment areas of about 70 000 to 700 000 inhabitants.
They had all provided outpatient dementia care for
3e15 years. Their standard service comprised diagnostic
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work-up for dementia and related diagnoses as well as
recommendation of risk reduction, dementia medica-
tion and non-pharmacological treatments. Principal
investigators of the centres were psychiatrists, neurolo-
gists or geriatricians with 6e13 years of experience in
dementia care.
Interventions
The experimental intervention (COTiD) was designed
to improve the patient’s and the primary carer’s daily
functioning, and was based on an evidence-based treat-
ment manual.6 19e23 COTiD consisted of 10 occupational
therapy sessions of 1 hour’s duration held over 5 weeks at
each patient’s home. In the diagnostic phase, comprising
three or four sessions, the occupational therapist
explored (1) the patient’s preferences and history of
daily activities; (2) their ability to perform activities and
to use compensatory strategies within the familiar envi-
ronment; (3) the possibilities of modifying the patient’s
home; (4) the carer’s activity preferences, problems in
care giving, coping strategies and abilities to supervise;
and (5) the interaction between carer and patient. In
a shared decision-making process during the goal setting
session, the patient and the carer selected the one or two
most meaningful activities out of a list of their prefer-
ences for daily activities to work on in occupational
therapy. During the treatment phase of five to six
sessions, the occupational therapist defined, together
with the patient and the carer, more effective compen-
satory and environmental strategies to adapt both the
environment and the selected activities to the patient’s
habits and cognitive abilities. Patient and carer were
taught how to use these suggested adaptations within
strategies, activities and the environment in order to
improve their performance of daily activities. In addition,
the carer received practical and emotional support and
was coached in effective supervision, problem-solving and
coping strategies by means of cognitive-behavioural
interventions. Detailed description of the experimental
intervention has been published elsewhere.23
For the German RCT, MG taught the content of the
translated treatment manual to 14 study-participant
occupational therapists in 16 h of seminars using
presentation, videos and role play with feedback and
group discussion. After the seminar and before the study
started, they needed to complete a full treatment series
for at least one pilot dyad of patient and carer. In the
study phase, the interventionists spent about 20 h per
patient for a full treatment series including 10 treatment
sessions, travel, reports and a multidisciplinary briefing.
In Germany, a series of 10e30 sessions is within the
normal range of time that occupational therapists use
for the treatment of older outpatients diagnosed as
having other diseases, such as stroke or rheumatoid
arthritis.
The control group received 1 h of COTC at the
patient’s home conducted by the same study interven-
tionists. Based on material of the German Alzheimer’s
Society, two occupational therapists with more than
5 years of experience in dementia care had prepared
a leaflet of 10 pages.24 25 The semistructured consulta-
tion was an explanation of 30 min of this leaflet and
a talk of 30 min on individual problems that arose from
the patient’s and carer’s needs. This included encour-
agement to stay active in everyday life, to maintain social
contacts and to use dementia services in the region for
which local addresses were listed in the leaflet. Occu-
pational therapists were taught the control intervention
within a 4 h seminar. Consultations of 30 min up to 1 h
duration about such issues are common in German
dementia care. A detailed description of the control
intervention as well as means of quality assurance in
experimental and control intervention has been
published elsewhere.26
Outcome measures
The primary endpoint was the patients’ change in daily
functioning from baseline to follow-up time points at
week 6, 16 and 26 measured with the performance scale
of the Interview for Deterioration in Daily Living Activ-
ities in Dementia (IDDD).27 This scale records the carer
rating of the patient’s need for assistance in the perfor-
mance of (1) washing oneself, (2) making tea or coffee,
(3) dressing, (4) combing one’s hair and brushing one’s
teeth, (5) eating, (6) using the toilet, (7) shopping, (8)
using the telephone, (9) preparing a meal, (10) cleaning
the house or doing minor repair work and (11) handling
finances. Each item is rated never¼0, seldom¼1, some-
times¼2, often¼3 or always¼4. The sum of scores
ranged from 0 to 44. Higher scores indicated a higher
need for assistance. Since the carer rating could not be
‘masked,’ daily functioning was additionally evaluated by
external raters fully ‘blind’ to the group assignment.
They rated videotapes of a challenging daily living task
and used the Perceive, Recall, Plan and Perform System
of Task Analysis (PRPP).28 For the PRPP, raters had to
define single steps of the performed activity, and they
identified any activity step in which errors of accuracy,
omission, repetition or timing occurred. The number of
activity steps rated as incorrectly performed was divided
by the total number of activity steps, resulting in an
independence score indicated as a percentage (100%¼
all steps are error-free; table 1).
Secondary endpoints included mood, quality of life,
resource utilisation and possible harms (table 1). Asses-
sors ‘blind’ for the group assignment, completed
measurements at the patient’s home at baseline and at
weeks 6, 16 and 26, and arranged a postal survey of carer
questionnaires at week 52. The assessors had a minimum
of 1 year’s professional experience with older or cogni-
tively impaired people. They attended an introductory
seminar of 8 h. The complete assessment was applied
during a 2 h visit at each patient’s home including (1)
handing out and explaining the questionnaires to the
carer; (2) interviewing the patient (Dementia Quality of
Life Instrument and Short-Form 12 Health Survey
Questionnaire) in a separate room; (3) videotaping the
patient; and (4) receiving back the carer questionnaires,
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checking it and clarifying answers if necessary. Seminar
descriptions and means of quality management for
assessment as well as detailed scheme and psychometric
properties of all measurement instruments have been
reported recently.26
All measurement instruments are validated and used
in dementia research.29 30 For the present study, we
translated the IDDD into German according to high
methodological standards with two independent forward
and backward translations, analysis of discrepancies and
final agreement by discussion with all translators. There
was no need to translate the PRPP because it was estab-
lished in The Netherlands and applied by Dutch raters.
There was one protocol amendment before recruitment
started. The Assessment of Motor and Process Skills was
replaced by the PRPP, because the Assessment of Motor
and Process Skills was not available in the German
language within the planned schedule.
Indicators of harm were defined as patient or carer
death, number of patients with admission to hospital
and number of nights in hospital. These indicators were
recorded in interviews with the carer at intervals of
5e7 weeks over 52 weeks. Study sites had to report severe
adverse events to the study centre immediately when
each occurred. We did not assume a direct association
between the defined harms and either the experimental
or the control intervention. However, increased daily
activities in the interventions group might have resulted
in a higher risk of falls or accidents and thus may indi-
rectly have led to more nights in hospital or, in the worst
case, to death.
Sample-size calculation
A sample size of 42 participants per group was calculated
to be necessary to detect an effect size of f¼0.10 on the
IDDD performance scale in an analysis of variance of two
groups and four time points, using a two-sided 5%
significance level, a power of 80% and a correlation of
0.7 between the measurement time points.31 According
to the Dutch original RCT, we expected a dropout rate of
10% at week 16, which was extrapolated to 40% at week
52. A 9-month inclusion period was anticipated as
necessary in order to recruit the 140 patients. Our
assumed effect size of f¼0.10 is based on a group-by-time
interaction and compatible with Cohen’s d¼0.20, which
corresponds to a small effect size, and any d over 0.8 is
large. Although the Dutch original RCT found effect
sizes of d¼2.4 in the IDDD performance scale at week
12, for this study the power was calculated much more
conservatively.
This was because we (1) introduced an active control
group, (2) investigated the programme effects under
varying care conditions in seven centres with interven-
tionists who were introduced in this new treatment and
were not as experienced as the Dutch study therapists
and (3) prolonged the follow-up period. Interim anal-
yses were not planned.
Randomisation and masking
The random allocation sequence was computer-gener-
ated with blocking by centre and groups of two persons,
without stratification and in a ratio of 1:1 by a statistician
from a distant site. After enrolment, study site physicians
requested randomisation via email. The statistician
emailed the individual allocation to COTiD or COTC
exclusively to the site interventionist and stored the
allocation list at his distant site which was not available to
any study site staff. The interventionist scheduled treat-
ment sessions, faxed records to the distant coordinating
study centre and kept all documents strictly separated
from any other site staff. This was in order to avoid
contamination. Since the numbers of home visits
differed in the experimental and control groups,
masking of patients and carers was not possible.
However, study information did not include any prefer-
ence for a special treatment ‘arm.’ Patients and carers
were asked to give no information about their treatment
package to assessors or study physicians. All study
personnel were ‘blind’ for group assignment, except the
interventionists. Agreement between the assessors’ esti-
mation of group assignment and the actual group
assignment was 61%, and thus slightly over the expected
50% of agreement by chance. The procedure of external
video rating ensured the full ‘blinding’ of the external
raters for the PRPP primary outcome measure. Inde-
pendent research assistants cleaned the videotapes of
Table 1 Measurements of secondary endpoints26
Endpoint Measurement
Patient’s initiative in daily activities Interview for Deterioration in Daily Living Activities in Dementia, initiative scale
Patient’s mood Cornell Scale for Depression in Dementia
Carer’s mood Center for Epidemiologic Depression Scale
Patient and carer’s quality of life Dementia Quality of Life Instrument, overall item
Short-Form 12 Health Survey Questionnaire physical
Short-Form 12 Health Survey Questionnaire mental
Carer’s interaction with patient Sense of Competence Questionnaire
Care by primary carer Resource Utilisation in Dementia, hours per day
Nursing home placement Resource Utilisation in Dementia, nights in nursing home (except respite care)
Harms No of adverse events
Resource Utilisation in Dementia, nights in hospital
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any hint of group assignment before they were rated by
two Dutch raters not involved in the trial treatment. In
order to establish the inter-rater reliability, we tested 10
double ratings of the same video by the two raters and
found an intraclass correlation coefficient of 0.9. Data
analysts were not ‘blind’ for the group assignment.
However, measurement time points and outcomes had
been published before data were available for analysis26
and any decision to remove patients from the analyses is
reported in the present publication.
Statistical methods
Data were entered via special MS Access entry masks
automatically controlling for data plausibility. In addi-
tion, sections of entered data were checked for typing
errors by hand, in order to ensure an error rate lower
than 0.2%. The primary intention-to-treat analysis
included all allocated participants with valid data
whether they did or did not receive the complete inter-
vention. For the IDDD and the PRPP measurements of
the primary outcome, we performed a multivariate
analysis of variance (MANOVA) with repeated measures
with two groups and four measurement time points at
baseline, weeks 6, 16 and 26. A univariate ANOVA with
five measurement time points (+postal assessment in
week 52) was carried out for the secondary outcomes
and the IDDD. We did not adjust for baseline values,
because we found no marked group differences. In
order to deal with missing data occurring not in the
primary but in the secondary outcomes, we performed
secondary intention-to-treat analyses with multiple data
imputation using the Full Information Maximum Like-
lihood method.32 We imputed data for all secondary
outcome measurements and all time points using SPSS
(V.19). In an additional analysis, we used the linear
mixed-effects models (MIXED) procedure in SPSS,
which allows an unequal number of repetitions and
a better handling of missing values.
All statistical tests were two-sided on an a level of 0.05.
Subgroup analyses were not planned.
RESULTS
Recruitment and participant flow
We prolonged the planned recruitment period from
August 2008 to April 2009 by one additional month, up
to May 2009. This was in order to recruit the intended
sample size. The 52-week follow-up was closed in May
2010. One hundred and forty-one participants were
recruited (Berlin: 19; Bonn: 21; Freiburg: 26; Karls-
ruhe: 15; Mainz: 24; Marburg: 21; Tu¨bingen: 15). The
flow chart (figure 1) shows that attrition following
randomisation did not lead to any significant group
differences.
Figure 1 Flow of participants
through the trial.
Assessed for eligibility (n=228)
Excluded (n=87)
Ineligible (n=47) 
Eligible but not recruited (n=40)
Allocated to occupational therapy (n=71) 
61 Received complete allocated intervention  
6 Allocated intervention was incomplete 
4 Did not receive allocated intervention (1 patient 
admitted to hospital; 2 withdrew without reason; 
1 withdrew as carer felt stressed)
Follow-up at 6 weeks (n=66) 
2 Lost for follow up 
3 Withdrew (1 no reason; 1 patient not 
convinced; 1 carer felt stressed) 
Allocation
and 
Intervention
Randomisation and baseline assessment (n = 141)
Follow-up at 16 weeks (n=59) 
2 Lost for follow up 
5 Withdrew (1 no reason; 1 patient not 
convinced; 3 carer felt stressed) 
Follow-up at 26 weeks (n=55) 
2 Lost for follow up 
1 Withdrew (patient ill) 
1 Carer died 
Follow-up at 52 weeks (n=54) 
1 Lost for follow up
Allocated to control (n=70) 
66 Received complete allocated intervention  
4 Did not receive allocated intervention 
(withdrew: 1 no reason; 2 carer ill; 1 carer felt 
stressed)
Follow-up at 6 weeks (n=63) 
2 Lost for follow up 
5 Withdrew (1 no reason; 1 patient ill; 1 carer felt 
stressed; 2 carer ill) 
Follow-up at 16 weeks (n=55) 
2 Lost for follow up 
5 Withdrew (1 patient ill; 2 carer not convinced; 
2 carer felt stressed) 
1 Patient admitted to nursing home 
Follow-up at 26 weeks (n=50) 
3 Lost for follow up 
1 Withdrew (1 patient ill) 
1 Patient died 
Follow-up at 52 weeks (n=50)
Follow up
Analysis
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Baseline characteristics
Randomisation did avoid imbalances in baseline char-
acteristics (table 2) and pretreatment assessment data
(table 3) except in one item. Participants in the control
group had more moderate to severe limitations in their
financial situation (14% vs 2%; p¼0.027). Because the
financial situation is not known as a predictive factor
for functional decline, we did not adjust for this
imbalance.33
Intervention delivery
Sixty-one of 71 (86%) allocated patientecarer dyads
received complete sessions in the COTiD group, 66 of 70
(94%) in the control group. In each group, four pairs
were lost before intervention. Six patientecarer dyads in
the COTiD had fewer than 10 sessions. Interventionists
rated the delivery of 20 predefined treatment subpro-
cesses, ranging from interviewing patient and carer to
training of simplified activities or supporting the carer in
supervision. They scored treatment delivery as 78% in
the COTiD group and 80% in the control group. Inter-
ventionists rated the patient’s adherence in 67 cases of
the COTiD group, from 15 as hindering the delivery of
treatment; 26 as neutral and 26 as facilitating. Rating
criteria were the patient’s cooperation during interview,
goal setting and training; the daily changing mental
capacity; collaboration with the carer; and the accep-
tance of innovations. Ratings of carers’ adherence were:
5, hindering; 15, neutral; and 47, facilitating. The carer
adherence was assessed with regard to the cooperation
during scheduling, interview, goal setting and training to
supervise; the encouragement of the patient; the
acceptance of support service; and the implementation
of innovations. The adherence of the participants in the
control group could not be rated, because interven-
tionists had no further contact after the consultation.
Outcomes
The MANOVA in 104 completers (COTiD: n¼54;
control: n¼50) revealed no significant groupetime
interaction effect in the primary outcome measurements
of patients’ daily functioning (figures 2, 3). Using the
arcsine transform34 for the PRPR percentage did not
change results (original: p¼0.243; arcsine-transform:
p¼0.216). An additional mixed-models analysis of all
randomised patients (N¼141) as recommended by
Coley and colleagues35 also revealed no significant
interactions for the IDDD (p¼0.340) and the PRPP
(p¼0.785); details are provided as supplementary online
material. Tables 3, 4 show the mean, SD and group
difference including 95% CIs of an ANOVA for all
outcomes. Patients’ daily functioning did not change
significantly over 26 weeks in either the experimental or
control group. In the postal 52-week follow-up, the
patients’ need for assistance increased in both groups,
and accordingly the carer’s hours of care for basic ADL
were higher. Two patients of the COTiD group were
placed in nursing homes 33 and 44 weeks after baseline
and one patient of the control group after 33 weeks.
To address the problem of missing data in single
measurement instruments, we performed a multiple
data imputation. We calculated a MANOVA over four
measurement time points for all primary and secondary
outcomes for all 104 completers. Ten different data
Table 2 Demographic and clinical characteristics
Community Occupational Therapy
in Dementia Programme Control
Analysed
(n[54)
Dropouts
(n[17)
Total
(n[71)
Analysed
(n[50)
Dropouts
(n[20)
Total
(n[70)
Age, years (SD) 78.0 (7.1) 77.2 (8.5) 77.8 (7.4) 78.7 (6.0) 78.3 (7.1) 78.5 (6.3)
Sex, female 29 (54%) 12 (71%) 41 (58%) 30 (60%) 10 (50%) 40 (57%)
Mini-Mental State Examination (SD) 20.4 (3.1) 19.0 (3.3) 20.2 (3.2) 20.7 (2.7) 20.3 (2.9) 20.7 (2.7)
Geriatric Depression Scale (SD) 6.9 (3.0) 5.6 (2.9) 6.5 (3.0) 5.2 (2.8) 6.1 (2.6) 5.5 (2.8)
Education
No school graduation 2 (4%) 1 (6%) 3 (4%) 1 (2%) 0 (0%) 1 (1%)
Middle school graduation (9 or 10 years) 41 (76%) 13 (76%) 54 (76%) 37 (74%) 15 (75%) 52 (74%)
High school graduation (12 or 13 years) 11 (20%) 3 (18%) 14 (20%) 12 (24%) 5 (25%) 17 (24%)
Financial situation as perceived by the carer
No limitation 40 (74%) 14 (82%) 54 (76%) 38 (76%) 13 (65%) 51 (73%)
Minor limitation 12 (22%) 1 (6%) 13 (18%) 3 (6%) 3 (15%) 6 (9%)
Moderate or severe limitation 1 (2%) 2 (12%) 3 (4%) 7 (14%) 4 (20%) 11 (16%)
No data 1 (2%) 0 (0.0%) 1 (1%) 2 (4%) 0 (0%) 2 (3%)
Primary carer
Age, years (SD) 65.4 (16.3) 63.1 (14.0) 64.9 (15.7) 65.9 (13.0) 61.4 (17.4) 64.5 (14.4)
Sex, female 38 (70%) 9 (53%) 47 (66%) 35 (70%) 18 (90%) 53 (76%)
Spouse 32 (59%) 8 (47%) 40 (56%) 31 (62%) 9 (45%) 40 (57%)
Daughter or son (in law) 20 (37%) 7 (41%) 27 (38%) 16 (32%) 9 (45%) 25 (36%)
Others 2 (4%) 2 (12%) 4 (6%) 3 (6%) 2 (10%) 5 (7%)
Living together (%) 41 (76%) 11 (65%) 52 (73%) 33 (66%) 14 (70%) 47 (67%)
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imputations did not reveal any significant timeegroup
interaction effects.
We also tested for study site differences at baseline and
found no significant differences in a MANOVA with the
factors study sites and intervention groups (F (66, 432)¼
1.079, p¼0.323). Furthermore, no study-site effect was
found in the primary outcome analysing IDDD
and PRPP data of baseline, and weeks 6, 16 and 26
(IDDD: F (6, 90)¼0.724, p¼0.631; PRPP: F (6, 90)¼
1.758, p¼0.117).
Harms
There were no differences between intervention and
control group, either in the number of adverse events or
in their severity. The study-site physicians judged all
adverse events as unrelated to trial treatment or assess-
ment contacts. In the total sample of all randomised
participants (n¼141), two deaths of patients (both in the
control group) and one death of a carer (in the COTiD
group) were reported. In the COTiD group, 14 patients
were admitted to hospital for an average of 15 nights,
and 10 patients in the control group for an average of
18 nights. There was no difference between the two
groups in average number of nights admitted to hospital
(F (1, 97)¼2.785, p¼0.1). All events were unrelated to
the occupational therapy sessions.
DISCUSSION
In the results of this study, a 10-session community
occupational therapy in dementia programme (COTiD)
was found to be no more beneficial than a one-session
consultation concerning short- and middle-term effects
on patients’ daily functioning. In both groups, the need
for assistance in basic and instrumental ADL and the
performance of a self-chosen daily living task remained
stable up to 6 months after baseline. No significant
group differences could be found on secondary
outcomes, which were quality of life and mood of patient
and primary carer; patient’s initiative in daily activities;
carer’s sense of competence in interaction with the
patient; carer’s hours of daily care; and patient’s nursing
home placement. There were no adverse events associ-
ated with experimental or control intervention.
Limitations
Despite an elaborate study design, there are several limi-
tations in this study. We analysed only 104 completer dyads
from 141 recruited pairs (74%). However, (1) baseline
data of completers and non-completers did not show an
imbalance; (2) dyads were maintained, whose data were
valid, and for whom treatment was intended but not
received in the complete ITT-analysis; (3) an additional
mixed model analysis of all randomised patients also did
not reveal any significant differences; and (4) the analysis
of the reduced patient sample with valid data did not show
even a tendency towards significant group differences.
Thus, the hypothesis of group differences must be
rejected, because the analysis of completers usually favours
results in the direction of group differences.
A second shortcoming was that following the common
introductory seminar, the start of the study differed among
the sites due to different time lines in administrative
matters and approval of the local ethic commissions.
Therefore, a common repetition seminar for the inter-
ventionists could not be arranged after the pilot training.
This may have led to some heterogeneity in the interven-
tion, especially because in Germany, 11 newly introduced
interventionists performed the treatment compared with
two experienced experts in the original Dutch trial. We
addressed this problem with feedback on videos of treat-
ment sessions the interventionists sent in. Furthermore, we
arranged telephone supervision on demand.
We consider the contamination of the control inter-
vention with knowledge from the experimental interven-
tion to be low, because any specific intervention such as
activity selection, simplification or training was precluded
by the limited time to carry out the control intervention.
Comparison
The Dutch RCT on the COTiD with waiting-control-
group design showed large effect sizes in the IDDD
performance scale at 6 and 12 weeks after baseline
Figure 2 Activities of Daily Living task performance of
Alzheimer’s patients following intense occupational therapy
compared with a single session control intervention; means
and 95% CIs of the Perceive, Recall, Plan and Perform System
of Task Analysis independence scale (N¼104 completers;
range: 100¼no errors to 0¼all errors). COTiD, Community
Occupational Therapy in Dementia Programme.
Figure 3 Need for assistance in Activities of Daily Living of
Alzheimer’s patients following intense occupational therapy
compared with a single-session control intervention; means
and 95% CIs of the Interview for Deterioration in Daily Living
Activities in Dementia performance scale (N¼104 completers;
range: 0¼never needed assistance to 44¼always needed
assistance). COTiD, Community Occupational Therapy in
Dementia Programme.
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(d¼2.3 and 2.4, respectively).6 Since the Dutch COTiD
programme demonstrated such highly positive effects,
we judged it as appropriate to conduct not an identical
replication, but a twofold transfer from the source to the
target country and from a mono-centre RCT design with
high expertise of interventionists to a pragmatic multi-
centre RCT design in routine care.36 The Dutch and the
German sample did not differ remarkably in cognition at
baseline (MMSE: 19 vs 20), but did differ in the need for
assistance (IDDD performance: 24 vs 15). The German
patients showed a low need for assistance at the begin-
ning of the study. This was comparable with the IDDD
values of the Dutch patients at the end of the treatment.
This may have caused a floor effect on the IDDD.
Another mono-centre RCT in the USA compared
community occupational therapy and a less intensive
telephone consultation in patients with probable
dementia (MMSE: 13).37 The authors found a small
effect size in daily functioning (d¼0.21). The initial
need of assistance in both studies was higher than in the
German sample. A systematic review of community
programmes in dementia38 reported one study on
exercise and behavioural management with beneficial
effects on daily functioning of patients with moderate
dementia (MMSE: 17); one trial on occupational therapy
with heterogeneous effects; and two studies on occupa-
tional therapy and music therapy with no significant
effects. A current German health-technology assessment
on non-drug therapies in Alzheimer’s disease did not
identify any further community occupational therapy
trials.39 The comparison of community intervention
trials reveals that study samples with a lower MMSE and
a higher need for assistance have a greater benefit than
those with higher initial cognitive and daily functioning.
Similarly, a standardised synopsis of ADL outcomes in
pharmacological dementia trials indicated that samples
with an MMSE between 17 and 10 have the greatest
benefit in ADL, while samples with higher MMSE scores
showed smaller effects.40 However, different baseline
scores of cognitive and daily functioning alone cannot
explain the major difference between the findings in this
German study and the positive results of the Dutch RCT.
Detailed process evaluation and exploratory analyses of
the study data might show whether variations in study-
site context and treatment performance influenced the
intervention’s effectiveness.
Clinical and research implications
Published evidence for the effectiveness of community
occupational therapy in dementia is heterogeneous, as
indicated by a Dutch trial with large positive effects on
daily functioning, a few USA trials with no or small
positive effects on ADL and this German study showing
that 10 sessions were not better than one consultation. A
preventive one-session consultation might be hypoth-
esised as beneficial for people with mild dementia and
an improved 10-session programme more specifically
adapted to the German healthcare system as beneficial
for dementia patients with a moderate need for assis-
tance in ADL, as shown in the Dutch study in which most
people with dementia had a moderate to high need for
assistance at baseline.
Although we had expected smaller effect sizes than in
the Dutch original trial due to a changed study design
with (1) the introduction of an active control group, (2)
a variance in treatment performance in several centres,
(3) a prolonged follow-up time and (4) rigorous reduc-
tion in the analysed sample to participants with valid
data, it remains surprising that no significant group
difference could be found in any of the primary or
secondary outcomes.
This study has shown that careful cross-national
comparisons are greatly needed, especially in complex
interventions, before they can be considered evidence-
based and implemented effectively in other healthcare
systems. Therefore, further analyses must investigate the
role of interventionists’ expertise and treatment perfor-
mance, and the role of participants’ needs and utilisa-
tion of healthcare resources, before conclusions on
international implementation of this intense occupa-
tional therapy intervention can be drawn.
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